题目内容

I don't doubt______________he will come on time.
[A] whether
[B] which
[C] what
[D] that

查看答案

搜索结果不匹配？点我反馈

更多问题

阅读下列一则1889年的柯达相机广告，并回答有关问题。
The KODAK
Anyone can use the Kodak．The operation of making a pictureconsists simply of pressing a button．One hundred instantaneous pic—tures are made without reloading．No dark room or chemicals are nec—essary．A division of Labor is offered，whereby all the work of finish—ing all the pictures is done at the factory，where the camera can besent to be reloaded．The operator need not Learn anything about photography．He can“Press the button”—we do the rest。
Send for a copy of KODAK PRIMER with sample photograph．
(1)将这段文案翻译成汉语。
(2)找出柯达的广告口号，并作简要的评点。

If the woman wants to see movies, what station should she watch？
[A] NBC.
[B] Super-Station.
[C] Nick-at-Nite.
[D] Three's Company.

[A] awareness
[B] concern
[C] attention
[D] intention

TEXT D
Less than a year ago, a new generation of diet pills seemed to offer the long-sought answer to our chronic weight problems. Hundreds of thousands of pound-conscious Americans had discovered that a drug combination known as "fen-phen" could shut off voracious appetites like magic, and the FDA had just approved a new drug, Redux, that did the same with fewer side effects. Redux would attract hundreds of thousands of new pill poppers within a few months.
But now the diet drug revolution is facing a backlash. Some of the nation's largest HMOs,including Aetna U. S. Healthcare and Prudential Healthcare, have begun cutting back or eliminatingreimbursement for both pills. Diet chains like Jenny Craig and Nutri System are backing away from them too. Several states, meanwhile, have restricted the use of fen-phen. Last week the Florida legislature banned new prescriptions entirely and called on doctors to wean current patients from the drug within 30 days; it also put a 90-day limit on Redux prescriptions. Even New Jersey doctor Sheldon Levine, who touted Redux last year on TV and in his book The Redux Revolution, has stopped giving it to all but his most obese patients.
The reason for all the retrenchment: potentially lethal side-effects. Over the summer,the FDA revealed that 82 patients had developed defects in their heart valves while on fen-phen, and that seven patients had come down with the same condition on Redux.
As if that weren't bad enough, physicians reported that a woman who had been taking fen-phen for less than a month died of primary pulmonary hypertension, a sometimes fatal Iung condition already associated with Redux. And an article in the Journal o f the American Medical Association last month confirmed earlier reports that both fen-phen and Redux can cause brain damage in lab animals.
These findings led the New England J ournal to publish an editorial admonishing doctors to prescride the drugs only for patients with severe obesity. Meanwhile, FDA asked drug makers to put more explicit warnings on fen-phen and Redux labels. Since mid-July, prescriptions for fen-phen have dropped 56%, and those for Redux 36%, according to IMS America, a pharmaceutical market research firm.
All that really does, however, is bring the numbers down to where they should have been all along. Manufacturers said from the start that their pills offered a short-term therapy for the obese,not for people looking to fit into a smaller bathing suit. FDA approved Redux with just such a caveat, and when limited to these patients, the drugs may still make sense ---- despite the risks v----because morbid obesity carries its own dangers, including heart disease, diabetes and stroke. Too often, however, Redux and fen-phen were peddled to all comers, almost like candy. The current backlash, says Levine, is a "roller coaster that never should have happened. "
The new pills seemed to be a solution to
[A] the problem of obesity that has obsessed the Americans for a long time.
[B] the problem that is of great weight and significance.
[C] the vital problem caused by the pills.
[D] the threatening situation we are facing in the long run.